← USPTO Trademark Applications

FIBROGEN

Cancelled TM78466454 Kind: cancelled Mar 20, 2026

Abstract

Recombinant collagen for clinical or pharmaceutical use; synthetic gelatin for clinical or pharmaceutical use; recombinant collagen for use as a dermal filler or as a pharmaceutical preparation for dermal implantation; prolyl hydroxylase inhibitors for clinical or pharmaceutical use; Recombinant collagen coating for use on labware and medical devices; Medical sponges that act as a hemostat; medical sponges that act as a tissue sealant; medical sponges composed primarily of recombinant collagen; medical sponges composed primarily of recombinant collagen and synthetic gelatin; Synthetic gelatin for research use; anti-connective tissue growth factor antibodies for research and diagnostic use; prolyl hydroxylase inhibitors for research use; recombinant collagen for use in manufacturing pharmaceutical products and veterinary products

Filing Date

2004-08-12